Mangoceuticals (MGRX) Competitors $1.54 +0.03 (+1.64%) Closing price 07/3/2025 03:28 PM EasternExtended Trading$1.54 0.00 (0.00%) As of 07/3/2025 04:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MGRX vs. BMGL, BDSX, BNR, CCM, MRAI, ENZ, BRTX, SSY, BGLC, and OTRKShould you be buying Mangoceuticals stock or one of its competitors? The main competitors of Mangoceuticals include Basel Medical Group (BMGL), Biodesix (BDSX), Burning Rock Biotech (BNR), Concord Medical Services (CCM), Marpai (MRAI), Enzo Biochem (ENZ), Biorestorative Therapies (BRTX), SunLink Health Systems (SSY), BioNexus Gene Lab (BGLC), and Ontrak (OTRK). These companies are all part of the "healthcare" industry. Mangoceuticals vs. Its Competitors Basel Medical Group Biodesix Burning Rock Biotech Concord Medical Services Marpai Enzo Biochem Biorestorative Therapies SunLink Health Systems BioNexus Gene Lab Ontrak Mangoceuticals (NASDAQ:MGRX) and Basel Medical Group (NASDAQ:BMGL) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, dividends, analyst recommendations, media sentiment, earnings, institutional ownership, risk and valuation. Does the media refer more to MGRX or BMGL? In the previous week, Mangoceuticals and Mangoceuticals both had 1 articles in the media. Mangoceuticals' average media sentiment score of 0.00 equaled Basel Medical Group'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Mangoceuticals 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Basel Medical Group 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is MGRX or BMGL more profitable? Basel Medical Group has a net margin of 0.00% compared to Mangoceuticals' net margin of -2,191.76%. Basel Medical Group's return on equity of 0.00% beat Mangoceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Mangoceuticals-2,191.76% -72.81% -66.58% Basel Medical Group N/A N/A N/A Do institutionals & insiders believe in MGRX or BMGL? 56.7% of Mangoceuticals shares are held by institutional investors. 16.0% of Mangoceuticals shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has preferable valuation & earnings, MGRX or BMGL? Basel Medical Group has higher revenue and earnings than Mangoceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMangoceuticals$511.08K15.63-$8.71M-$4.64-0.33Basel Medical Group$10.00M3.18N/AN/AN/A SummaryBasel Medical Group beats Mangoceuticals on 4 of the 7 factors compared between the two stocks. Get Mangoceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MGRX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MGRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MGRX vs. The Competition Export to ExcelMetricMangoceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.99M$2.41B$5.49B$9.02BDividend YieldN/A1.77%5.38%4.10%P/E Ratio-0.338.9827.4720.28Price / Sales15.63669.86408.86121.46Price / CashN/A157.0736.6357.47Price / Book0.364.638.095.68Net Income-$8.71M$31.34M$3.17B$248.96M7 Day Performance-10.69%3.25%2.81%3.30%1 Month Performance-30.72%6.80%3.67%5.20%1 Year Performance-97.76%1.89%35.41%21.37% Mangoceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MGRXMangoceuticals0.882 of 5 stars$1.55+1.6%N/A-97.8%$7.99M$511.08K-0.333News CoverageGap UpBMGLBasel Medical GroupN/A$2.24-7.1%N/AN/A$41.33MN/A0.0036News CoverageBDSXBiodesix3.4113 of 5 stars$0.28+2.4%$1.75+535.9%-82.8%$40.33M$74.46M-0.95220Gap UpBNRBurning Rock BiotechN/A$3.44+2.1%N/A-44.8%$37.01M$70.67M-1.821,390CCMConcord Medical Services0.8825 of 5 stars$5.73-1.2%N/A-38.7%$24.87M$52.60M0.00970News CoverageMRAIMarpaiN/A$1.27+0.8%N/A+87.5%$19.95M$34.87M-0.48150Gap UpENZEnzo BiochemN/A$0.33-14.8%N/A-68.4%$17.03M$29.09M0.00520Gap DownHigh Trading VolumeBRTXBiorestorative Therapies2.8001 of 5 stars$1.71+4.2%$18.00+953.4%-15.3%$12.82M$400K-1.167SSYSunLink Health SystemsN/A$0.92-5.0%N/A+16.6%$6.49M$31.09M6.591,376Positive NewsBGLCBioNexus Gene Lab0.3704 of 5 stars$2.67-2.6%N/A+33.5%$4.81M$9.51M0.0030Gap DownOTRKOntrak2.769 of 5 stars$1.05-21.1%$45.00+4,185.7%-83.9%$4.43M$10.85M-0.07250News CoverageNegative News Related Companies and Tools Related Companies BMGL Alternatives BDSX Alternatives BNR Alternatives CCM Alternatives MRAI Alternatives ENZ Alternatives BRTX Alternatives SSY Alternatives BGLC Alternatives OTRK Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MGRX) was last updated on 7/4/2025 by MarketBeat.com Staff From Our Partners[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredHave you heard of “E.I.”?Inside Expert: New "E.I." Tech Could Be Poised For 200,000% Growth Meta, Apple, and even NASA are rushing t...Behind the Markets | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredTop Picks for Trump’s Pro-Crypto AmericaMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mangoceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mangoceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
